1. ALLA AKTIER
  2. NYHETER
  3. LUMITO

Lumito

Nyheter Lumito Nyheter alla bolag
Affiliate
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

First factory produced SCIZYS reagent kit is now available

The first batch of Lumito's reagent intended for end customer sales is now produced by Lumito's production partner, Uniogen Oy.

Lumito has collaborated with Uniogen Oy (formerly Kaivogen Oy) for over 15 months to prepare the production of the nanoparticle-based reagent kit belonging to the company's digital pathology solution.

- It feels great that a crucial ingredient in our solution now is produced so that we are completely ready when the next piece of the puzzle comes into place and then be able to launch SCIZYS, comments Mattias Lundin, Lumitos CEO.

SCIZYS Erbium Kit forms an essential part of the company's first product, which also consists of a digital scanner.

For further information, please contact:

Mattias Lundin, CEO Lumito
E-mail: ml@lumito.se
Ph: +46 76 868 45 09 

Lumito

Lumito specialises in medical technology for digital pathology. Through its proprietary and patented technology, Lumito aims to provide healthcare providers with a powerful tool to meet the demands for fast and safe tissue diagnostics in personalised healthcare. The technology enables higher-contrast images without irrelevant background information, making it easier for pathologists to find cancer indications. The technology, based on Up Converting NanoParticles (UCNP), has the potential to significantly improve the diagnosis of tissue samples through higher quality analyses and shortened analysis times. The method has several potential applications, but Lumito has focused primarily on digital pathology and first on a release of SCIZYS by Lumito for use in research laboratories. The company is a spin-off of a research group at the Department of Atomic Physics and Laser Centre. www.lumito.se/en

The share is traded on NGM Nordic SME under the name LUMITO, and Mentor is Mangold Fondkommission.

Image Attachments
SCIZYS Erbium Kit

Attachments
First factory produced SCIZYS reagent kit is now available

Datum 2023-10-17, kl 10:00
Källa MFN
Bifogade filer
First factory produced SCIZYS reagent kit is now available
SCIZYS Erbium Kit